[Increasing trend in prescription of methylphenidate in general practices in the north-east of The Netherlands, 1998-2003]
- PMID: 16114292
[Increasing trend in prescription of methylphenidate in general practices in the north-east of The Netherlands, 1998-2003]
Abstract
Objective: To obtain information on the frequency of and the indications for prescription of methylphenidate in general practices in the north-east of The Netherlands.
Design: Descriptive.
Method: Data were collected from 1998 to 2003 from 6 general practices in the north-east of The Netherlands (17 general practitioners, approximately 30,000 patients) that were affiliated to the Registration Network in Groningen. The number of new and existing patients who were prescribed methylphenidate was calculated by age group per 1000 person-years per calendar year. The indication on which the drug was prescribed was looked at, as was the number of patients who were referred to a specialist on that indication.
Results: The number of new users per 1000 person-years more than doubled from 17 in 1999 to 42 in 2003. In all years studied the highest number of new users fell into the age group 5-9 years. The total number of users per 1000 person-years tripled (boys: 1.8 in 1998 and 6.2 in 2003; girls: 0.5 in 1998 and 0.8 in 2003). The prevalence of use in boys was 3 to 8 times as high as that of girls and increasing more quickly. In people under 59 years of age attention deficit hyperactivity disorder (ADHD) was the most frequent indication (55%). In the group aged > or = 60 years methylphenidate was mainly prescribed in the palliative phase of somatic morbidity. Over half of the 140 new patients (57%) were referred nor to a specialist in the year before neither in the year after the first prescription of methylphenidate.
Comment in
-
[Better health care for children and adolescents with attention deficit hyperactivity disorder].Ned Tijdschr Geneeskd. 2005 Jul 30;149(31):1723-5. Ned Tijdschr Geneeskd. 2005. PMID: 16114286 Dutch.
-
[Better health care for children and adolescents with attention deficit hyperactivity disorder].Ned Tijdschr Geneeskd. 2005 Dec 10;149(50):2822. Ned Tijdschr Geneeskd. 2005. PMID: 16385839 Dutch. No abstract available.
Similar articles
-
[Use of methylphenidate among children in Iceland 1989-2006].Laeknabladid. 2007 Dec;93(12):825-32. Laeknabladid. 2007. PMID: 18057472 Icelandic.
-
[Hyperactivity and prescription of Ritalin in the canton of Vaud (Switzerland), 2002].Rev Epidemiol Sante Publique. 2007 Oct;55(5):357-63. doi: 10.1016/j.respe.2007.05.008. Epub 2007 Sep 21. Rev Epidemiol Sante Publique. 2007. PMID: 17889474 French.
-
Prescription of methylphenidate to children and youth, 1990-1996.CMAJ. 2001 Nov 27;165(11):1489-94. CMAJ. 2001. PMID: 11762572 Free PMC article.
-
ADHD and the rise in stimulant use among children.Harv Rev Psychiatry. 2008;16(3):151-66. doi: 10.1080/10673220802167782. Harv Rev Psychiatry. 2008. PMID: 18569037 Review.
-
An update on central nervous system stimulant formulations in children and adolescents with attention-deficit/hyperactivity disorder.Ann Pharmacother. 2009 Jun;43(6):1084-95. doi: 10.1345/aph.1L523. Epub 2009 May 26. Ann Pharmacother. 2009. PMID: 19470858 Review.
Cited by
-
Use of attention-deficit/hyperactivity disorder medication among older adults in Denmark.Br J Clin Pharmacol. 2018 Jul;84(7):1505-1513. doi: 10.1111/bcp.13569. Epub 2018 Apr 22. Br J Clin Pharmacol. 2018. PMID: 29493809 Free PMC article.
-
Less discontinuation of ADHD drug use since the availability of long-acting ADHD medication in children, adolescents and adults under the age of 45 years in the Netherlands.Atten Defic Hyperact Disord. 2010 Dec;2(4):213-20. doi: 10.1007/s12402-010-0044-9. Epub 2010 Nov 30. Atten Defic Hyperact Disord. 2010. PMID: 21258431 Free PMC article.
-
Impact of attention-deficit/hyperactivity disorder (ADHD) on prescription dug spending for children and adolescents: increasing relevance of health economic evidence.Child Adolesc Psychiatry Ment Health. 2007 Nov 15;1(1):13. doi: 10.1186/1753-2000-1-13. Child Adolesc Psychiatry Ment Health. 2007. PMID: 18005403 Free PMC article.
-
Lisdexamfetamine dimesylate: a new therapeutic option for attention-deficit hyperactivity disorder.CNS Drugs. 2012 Aug 1;26(8):691-705. doi: 10.2165/11634340-000000000-00000. CNS Drugs. 2012. PMID: 22762726 Review.
-
In utero antidepressant exposure not associated with ADHD in the offspring: A case control sibling design.Front Pharmacol. 2022 Nov 10;13:1000018. doi: 10.3389/fphar.2022.1000018. eCollection 2022. Front Pharmacol. 2022. PMID: 36438827 Free PMC article.